PKC?II activation requires nuclear trafficking for phosphorylation and Mdm2-mediated ubiquitination

被引:3
|
作者
Min, Xiao [1 ]
Wang, Shujie [1 ]
Zhang, Xiaohan [1 ,2 ]
Sun, Ningning [1 ]
Kim, Kyeong-Man [1 ]
机构
[1] Chonnam Natl Univ, Coll Pharm, Dept Pharmacol, Gwangju, South Korea
[2] Guizhou Univ, Sch Pharmaceut Sci, Guiyang, Peoples R China
基金
新加坡国家研究基金会;
关键词
PROTEIN-KINASE-C; ACTIN CYTOSKELETON; MAMMALIAN-TISSUES; BETA-II; MOTIF; LOCALIZATION; ENDOCYTOSIS; RECEPTORS; PROENZYME; DOMAINS;
D O I
10.26508/lsa.202201748
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
PKC beta II, a conventional PKC family member, plays critical roles in the regulation of a variety of cellular functions. Here, we employed loss-of-function approaches and mutants of PKC beta II with altered phosphorylation and protein interaction behaviors to identify the cellular mechanisms underlying the activation of PKC beta II. Our results show that 3-phosphoinositide-dependent protein kinase-1 (PDK1)-mediated constitutive phosphorylation of PKC beta II at the activation loop (T500) is required for phorbol ester-induced nuclear entry and subsequent Mdm2-mediated ubiquitination of PKC beta II, whereas ubiquitination of PKC beta II is required for the PDK1-mediated inducible phosphorylation of PKC beta II at T500 in the nucleus. After moving out of the nucleus, PKC beta II interacts with actin, undergoes inducible mTORC2-mediated phosphorylation at the turn motif (T641), interacts with clathrin, and then translocates to the plasma membrane. This overall cascade of cellular events intertwined with the phosphorylation at critical residues and Mdm2-mediated ubiq-uitination in the nucleus and along with interactions with actin and clathrin plays roles that encompass the core processes of PKC activation.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity
    Min, Xiao
    Zhang, Xiaohan
    Sun, Ningning
    Acharya, Srijan
    Kim, Kyeong-Man
    [J]. BIOCHEMICAL PHARMACOLOGY, 2019, 170
  • [2] Mdm2-mediated ubiquitination of PKCβII is responsible for insulin-induced heterologous desensitization of dopamine D3 receptor
    Zeng, Xingyue
    Wu, Chengyan
    Cao, Yongkai
    Li, Huijun
    Zhang, Xiaohan
    [J]. FEBS LETTERS, 2024, 598 (04) : 400 - 414
  • [3] Mechanistic studies of MDM2-mediated ubiquitination in p53 regulation
    Brooks, Christopher L.
    Li, Muyang
    Gu, Wei
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (31) : 22804 - 22815
  • [4] Akt enhances Mdm2-mediated ubiquitination and degradation of p53
    Ogawara, Y
    Kishishita, S
    Obata, T
    Isazawa, Y
    Suzuki, T
    Tanaka, K
    Masuyama, N
    Gotoh, Y
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21843 - 21850
  • [5] MDM2-Mediated Ubiquitination of RXRβ Contributes to Mitochondrial Damage and Related Inflammation in Atherosclerosis
    Zeng, Yi
    Cao, Ji
    Li, Chun-Xia
    Wang, Chun-Yan
    Wu, Ruo-Man
    Xu, Xiao-Le
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [6] MDM2-mediated ubiquitination of LKB1 contributes to the development of diabetic cataract
    Li, Xiao
    Sun, Xiaowei
    Li, Li
    Luo, Yao
    Chi, Yingjie
    Zheng, Guangying
    [J]. EXPERIMENTAL CELL RESEARCH, 2022, 417 (01)
  • [7] Melatonin improves stroke through MDM2-mediated ubiquitination of ACSL4
    Ji, Qing
    Zhang, Le
    Ye, Hui
    [J]. AGING-US, 2024, 16 (02): : 1925 - 1937
  • [8] TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation
    Bae, Seunghee
    Jung, Jin Hyuk
    Kim, Karam
    An, In-Sook
    Kim, Soo-Yeon
    Lee, Jae Ho
    Park, In-Chul
    Jin, Young-Woo
    Lee, Su-Jae
    An, Sungkwan
    [J]. FEBS LETTERS, 2012, 586 (19) : 3057 - 3063
  • [9] TrkA promotes MDM2-mediated AGPS ubiquitination and degradation to trigger prostate cancer progression
    Zhang, Yu
    Huang, Zhenlin
    Li, Keqiang
    Xie, Guoqing
    Feng, Yuankang
    Wang, Zihao
    Li, Ningyang
    Liu, Ruoyang
    Ding, Yinghui
    Wang, Jun
    Yang, Jinjian
    Jia, Zhankui
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [10] Escape, or Vanish: Control the Fate of p53 through MDM2-Mediated Ubiquitination
    Wei, Jinlian
    Yang, Yingrui
    Lu, Mengchen
    Xu, Lili
    Liu, Fang
    Yuan, Zhenwei
    Bao, Qichao
    Jiang, Zhengyu
    Xu, Xiaoli
    Guo, Xiaoke
    Zhang, Xiaojin
    You, Qidong
    Sun, Haopeng
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (02) : 174 - 189